Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/22/2022 | $7.75 → $7.25 | Neutral | Cantor Fitzgerald |
| 12/10/2021 | $8.75 → $7.75 | Neutral | Cantor Fitzgerald |
| 11/23/2021 | Neutral | Cantor Fitzgerald | |
| 11/23/2021 | $8.75 | Neutral | Cantor Fitzgerald |
| 9/13/2021 | $12.00 | Buy | ROTH Capital |
| 9/3/2021 | Buy | Desjardins | |
| 9/3/2021 | $15.00 | Buy | Desjardins |
Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.25 from $7.75 previously
Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.75 from $8.75 previously
Cantor Fitzgerald initiated coverage of High Tide with a rating of Neutral
The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth The Company Also Shares Details of Its Q3 2025 Earnings Event CALGARY, AB, Aug. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2025. Management Guidance Range (Expres
Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase
CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com
6-K - High Tide Inc. (0001847409) (Filer)
6-K - High Tide Inc. (0001847409) (Filer)
EFFECT - High Tide Inc. (0001847409) (Filer)
The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth The Company Also Shares Details of Its Q3 2025 Earnings Event CALGARY, AB, Aug. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2025. Management Guidance Range (Expres
The Company Generates $4.9 Million in Free Cash Flow Daily Same Store Sales Across the Canna Cabana Network Increased by 6.2% Year Over Year The Company Discloses That it is in Exclusive Discussions Related to a Transaction with a Leading German Medical Cannabis Importer and Wholesaler This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated August 31, 2023, to its short form base shelf prospectus dated August 3, 2023. The Company Now Operates 200 Canna Cabana Locations Across Canada and Continues to be the Largest Cannabis Retail Brand in the CountryDuring February and March 2025, Canna Cabana Held a 12% Share of the Cannabis R
Same store sales increased 5% year over year, representing the fastest pace of growth during the past four quarters Cabana Club loyalty program exceeds 1.76 million members in Canada, with ELITE memberships exceeding 81,000 and growing at its fastest pace since inception This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated August 31, 2023, to its short form base shelf prospectus dated August 3, 2023. High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars1, Delivers Quarterly Revenue of $142.5 Million, an All-Time Record. This Represents an Increase of 11% Year Over Year, 3% Sequential
Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase
CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com
CALGARY, AB, May 30, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today the voting results from its annual general and special meeting of shareholders of the Company held on May 29, 2025 (the "Meeting"). Each nominee listed in the Company's management information circular dated April 17, 2025, was elected as a director of the Company. Each of the following five nominees proposed by management was